Senator Hassan Meets with Drug Enforcement Administration Leaders in NH

BEDFORD – U.S. Senator Maggie Hassan visited the U.S. Drug Enforcement Administration (DEA)’s New Hampshire office on Tuesday, where officials briefed her on current drug trends across the state and the agency’s strategic partnerships with local communities. 

During her visit, Senator Hassan toured the facility’s temporary on-site laboratory, which supports the DEA Manchester District Office’s response to local drug threats. She was also briefed on plans for a new regional DEA laboratory in Londonderry that will serve the New England region when it opens in 2026, accelerating the testing of drug evidence and strengthening investigations across the region.

“The dedicated law enforcement agents at DEA are working tirelessly to keep deadly drugs like fentanyl out of New Hampshire communities,” said Senator Hassan. “I will continue to work to ensure that our law enforcement partners have the resources and tools that they need to protect our neighborhoods and combat drug trafficking across the Granite State and the country.”

Senator Hassan has led efforts to stop drug trafficking and support communities devastated by the fentanyl crisis. In September, Senator Hassan reintroduced bipartisan legislation to curb the spread of rapidly evolving synthetic drugs by allowing the DEA to restrict and penalize substances that have a substantially similar chemical structure and effect on the body as fentanyl. In April, Senator Hassan and colleagues’ FEND Off Fentanyl Act, which targets the illicit fentanyl supply chain and will impose sanctions on fentanyl traffickers, was signed into law. Senator Hassan also developed and help pass into law the END FENTANYL Act, which helps Customs and Border Protection crack down on fentanyl trafficking at the border.

###